Operational updates
Pharming Group N.V. announces the reimbursement of RUCONEST® in Spain
Pharming Group announces that an agreement has been reached with the Spanish Ministry of Health to grant reimbursement for RUCONEST® (conestat alfa) in Spain.
We are delighted with this positive reimbursement decision by the Spanish Ministry of Health, as it means patients in Spain in need of new treatment options for hereditary angioedema will now be able to access RUCONEST®
- Sijmen de Vries - CEO